Solventum Corp | SOLV - Equity Capital And Reserves


Solventum Corp reported $4.99B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Cencora USD 1.91B 400.31M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
West Pharmaceutical Services USD 3.18B 124.5M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025